The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical trial of eribulin in advanced or recurrent cervical cancer (CC).
 
Jocelyn Garcia
No Relationships to Disclose
 
Yvonne Gail Lin
Consulting or Advisory Role - Advaxis; ClearPath Development Company
Research Funding - Array BioPharma; Astex Pharmaceuticals
Travel, Accommodations, Expenses - Array BioPharma
 
Stan Louie
Leadership - C5Rx
Stock and Other Ownership Interests - C5Rx; Gilead Sciences
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - C5Rx; OpRx
 
EunJeong Yoo
No Relationships to Disclose
 
Denice D Tsao-Wei
No Relationships to Disclose
 
Katherine E. Tierney
No Relationships to Disclose
 
Laurie Leigh Brunette
No Relationships to Disclose
 
Koji Matsuo
No Relationships to Disclose
 
Huyen Q. Pham
No Relationships to Disclose
 
Annie A. Yessaian
No Relationships to Disclose
 
Susan G. Groshen
No Relationships to Disclose
 
Grace Facio
Research Funding - Aeterna Zentaris (Inst); Array BioPharma (Inst); Astex Pharmaceuticals (Inst); Boston Biomedical (Inst); Janssen Research & Development (Inst)
 
Kristy Watkins
No Relationships to Disclose
 
Lynda D. Roman
No Relationships to Disclose
 
Laila I. Muderspach
No Relationships to Disclose
 
Agustin A. Garcia
Honoraria - Pfizer
Consulting or Advisory Role - Amgen; Novartis